Navigation Links
Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
Date:3/5/2008

LOS ANGELES, March 5 /PRNewswire/ -- Vista Partners announced today that it has updated coverage and has issued a $3.52 price target on Inovio Biomedical Corporation (Amex: INO). "Inovio has compelling pre-clinical and clinical data regarding the ability of their technology to significantly enhance the potency of DNA vaccines, with positive interim human results from three independent clinical studies. The company's technology is further validated from license agreements with two of the world's big five vaccine companies, Merck and Wyeth, plus multiple other partnerships and collaborations," said Ross Silver, Director of Research for Vista Partners. For more information and to download the report, please visit the Vista Partners website at http://www.vistap.com.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff has backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Inovio Biomedical Corporation:

Inovio Biomedical (AMEX:INO) is focused on developing multiple DNA-based immunotherapies. Inovio is a leader in developing
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
2. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Provista Awards Agreement to Spheris
5. Synvista Therapeutics to be Featured on Wallst.net
6. Synvista Therapeutics to Present at the BIO InvestorForum 2007
7. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
8. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
9. Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com
10. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
11. DW Healthcare Partners Announces the Sale of Tandem Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 Mapp ... experimental ZMapp™ antibody therapeutic to fight the Ebola ... difficult and time-consuming the production of pharmaceuticals can ... research publisher said that while some may be ... this compound, those with industry knowledge are well ...
(Date:10/20/2014)... , October 20, 2014 , ... (GI) disorders and the delivery of care has revealed ... and worrying inequalities in the provision of healthcare services ... was commissioned by United European Gastroenterology (UEG), have been ... and public awareness of the burden of GI disorders ...
(Date:10/20/2014)... Earle Martin , Chief Executive ... Ellen Teplitzky, an experienced attorney specializing in business ... has joined the firm as Director of Legal ... NDA Partners provides legal services, including research, ... top law firms and their clients in cases ...
(Date:10/19/2014)... , Oct. 19, 2014 NextCODE Health, which enables ... genome in real time, today announced the launch of its ... Exchange , at the American Society of Human Genetics (ASHG) ... learn more, sign up and apply for free beta access, ... features and benefits can be viewed here . ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3
... 29 Vical Incorporated,(Nasdaq: VICL ) today announced ... months and nine months ended September 30, 2008,before the ... a,conference call and webcast to discuss the financial results ... Wednesday, November 5. The call is,open on a listen-only ...
... (TSX, FSE: "HBP") today announced financial results for the ... year, the Company continued to make progress,with its development ... Alpha-2b. The following are selected highlights during,the 2008 fiscal ... -- DOS47/L-DOS47 ...
... Animal Data Demonstrates Selective Survival Advantage of ... Viral Loads, WASHINGTON and RICHMOND, Calif., Oct. ... announced today the presentation,of data demonstrating that human ... infection by treatment with zinc finger DNA-binding,protein nucleases ...
Cached Biology Technology:Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results 2Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results 3Helix BioPharma Corp. Announces Fiscal 2008 Results 2Helix BioPharma Corp. Announces Fiscal 2008 Results 3Helix BioPharma Corp. Announces Fiscal 2008 Results 4Helix BioPharma Corp. Announces Fiscal 2008 Results 5Helix BioPharma Corp. Announces Fiscal 2008 Results 6Helix BioPharma Corp. Announces Fiscal 2008 Results 7Helix BioPharma Corp. Announces Fiscal 2008 Results 8Helix BioPharma Corp. Announces Fiscal 2008 Results 9Helix BioPharma Corp. Announces Fiscal 2008 Results 10Helix BioPharma Corp. Announces Fiscal 2008 Results 11Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5
(Date:10/15/2014)... non-traditional biophysics textbook and it describes how life functions ... discovery into biological systems and provides an understanding of ... about how our genes make proteins that control the ... in an organism. It quantifies the principles of life ... found on both large and small scales. The book ...
(Date:10/15/2014)... Fred Alt will be awarded the 44th Rosenstiel Award ... for his pioneering research exploring the mechanisms of genomic ... cancer cells. Alt is the second alumnus to win ... Nobel Prize in 2003. , Alt is the Charles ... at Harvard Medical School and an investigator at the ...
(Date:10/14/2014)... – Scientists have sequenced the house fly genome for ... might expect from an insect that thrives in pathogen-rich ... Oct. 14 in the journal Genome Biology , ... and of how flies quickly adapt to resist insecticides, ... house flies (Musca domestica) carry and transmit more than ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2
... At noon, it was black as night. It was May ... day was at hand. Accounts of that day, which became ... meals by candlelight, night birds coming out to sing, flowers ... this day has been solved by researchers at the University ...
... of Science Picks, discover details about the recent major ... out about a hypothetical earthquake scenario unveiled for Southern ... the Hayward fault line. Learn about climate change impacts ... attend a briefing on the issue, how mineral production ...
... have identified specific molecules in the brain that are ... cells, which, when activated, can transform into neurons (nerve ... published online this week in the Proceedings of the ... earlier paper (published in the May issue of Stem ...
Cached Biology News:Mystery of infamous 'New England Dark Day' solved by 3 rings 2USGS science picks -- leads, feeds and story seeds 2USGS science picks -- leads, feeds and story seeds 3USGS science picks -- leads, feeds and story seeds 4USGS science picks -- leads, feeds and story seeds 5USGS science picks -- leads, feeds and story seeds 6USGS science picks -- leads, feeds and story seeds 7USGS science picks -- leads, feeds and story seeds 8USGS science picks -- leads, feeds and story seeds 9USGS science picks -- leads, feeds and story seeds 10 Brain stem cells can be awakened, say Schepens scientists 2
A univariate (peak height or area) quantitative multi-component analysis package....
... The AquaMax DW4 liquid handling system ... thorough washing all in one instrument. The ... for dispensing and plate washing96-, 384- and ... microplate washing. AquaMax DW4 has been optimized ...
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
... series embodies all aspects of classical microscopy ... powerful Achromatic Super Contrast (ASC) objectives coupled ... this microscope combines flexibility and professional microscopy ... B1 series, the DM-B1 steps into the ...
Biology Products: